
MGA’s Latest Work Examining Digital Health Tools
MGA has released a new report today for the Coalition for Affordable Prescription Drugs (CAPD), “Patent Thickets and Lost Drug Savings.”
MGA has released a new report today for the Coalition for Affordable Prescription Drugs (CAPD), “Patent Thickets and Lost Drug Savings.”
The Biosimilars Council released the following statement in response to the new MGA report authored by Alex Brill and Christy Robinson.
MGA has released a new report today for the Coalition for Affordable Prescription Drugs (CAPD), “Patent Thickets and Lost Drug Savings.”
A new MGA white paper from CEO Alex Brill and Principal Christy Robinson shows a positive outlook for biosimilar coverage in the commercial medical benefit.
MGA releases an updated report, “Biosimilar Market Opportunities in Ophthalmology.”
In a newly released report, MGA highlights the broad economic impact of Otsuka Pharmaceutical in the U.S. operations.